| GTO ID | GTC0832 |
| Trial ID | ChiCTR1900027577 |
| Disease | Prostate Cancer |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Chimeric Antigen Receptor T Cells (CART) Therapy in prostatic cancer (CaP) |
| Year | 2019 |
| Country | China |
| Company sponsor | The Fifth Hospital Affiliated to Zhongshan University |
| Cohort 1 | |||||||
|
|||||||